human chorionic gonadotropin

also known as hCG · Human Menopausal Gonadotropin · Pregnyl · hMG · Choriomon · human chorionic gonadotrophin · urinary HCG · Epifasi · +20 more

Protein / enzyme biologic targets LHCGR via activation

Developed for: infertility disorder · female infertility · ovarian hyperstimulation syndrome · acute graft versus host disease · Kallmann syndrome · Klinefelter syndrome · pregnancy disorder · azoospermia
+13 more
· hypogonadotropic hypogonadism · ischemic stroke · male infertility · obesity disorder · ovarian dysfunction · polycystic ovary syndrome · primary ovarian failure · traumatic brain injury · anovulation · gonadal disorder · oligospermia · ovarian disorder · Somatomedin, embryonic
Investigated by: Royan Institute · University Hospital Brussels · The Egyptian IVF-ET Center · Masonic Cancer Center, University of Minnesota · Reproductive & Genetic Hospital of CITIC-Xiangya · Rigshospitalet, Denmark
+48 more
· Stem Cell Therapeutics Corp. · ART Fertility Clinics LLC · Ain Shams University · Alexandria University · Assiut University · Azienda USL Modena · Beijing Children's Hospital · CRG UZ Brussel · Cairo University · Create Fertility Center · Dr. Emma's Corporation · Embryolab Fertility Clinic · Eugonia · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Ferring Pharmaceuticals · Fudan University · Georgios Papadakis · Granata Bio Corporation · Gulhane School of Medicine · Hadassah Medical Organization · Hue University of Medicine and Pharmacy · Human Reproduction & Genetics Foundation · IBSA Institut Biochimique SA · IVI Madrid · Jinling Hospital, China · Mansoura University · Martin Blomberg Jensen · Merck KGaA, Darmstadt, Germany · Michigan State University · Mount Sinai Hospital, Canada · Nanjing University School of Medicine · Organon and Co · Pakistan Air Force (PAF) Hospital Islamabad · Peter Humaidan · Peter Kovacs MD · Servy Massey Fertility Insititute · Shiraz University of Medical Sciences · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tampere University Hospital · The Fourth Affiliated Hospital of Zhejiang University School of Medicine · The Second Hospital of Shandong University · The University of Hong Kong · Tongji Hospital · US Department of Veterans Affairs · University of Calgary · University of California, San Francisco · University of Washington · Yazd Research & Clinical Center for Infertility

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

Milestone	Jurisdiction	Brand	Indication	Date	Sentence it was read from
Approved	US (FDA)	PREGNYL	—	1976-10-20	fda.gov ↗

Trials 62 · started per year

today

US approved 1976

197619771978197919801981198219831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 02 trials
Phase 0	NCT02265861	Jan 2010 → Jun 2012	polycystic ovary syndrome	Nanjing University School of Medicine	Completed	No outcome recorded
Phase 0	NCT01414673	Apr 2009 → Jul 2011	—	University Hospital Brussels	Completed	No outcome recorded
Phase 13 trials
Phase 1	NCT06754332	Apr 2025 → Apr 2028 expected	primary ovarian failure	The Fourth Affiliated Hospital of Zhejiang University School of Medicine	Not yet recruiting	No outcome recorded
Phase 1	NCT03735030	Nov 2018 → Aug 2019	infertility disorder	IBSA Institut Biochimique SA	Completed	No outcome recorded
Phase 1	NCT03418896	Jan 2018 → Oct 2022	calcium metabolic disease, hypogonadism, kidney disorder	Martin Blomberg Jensen	Completed	No outcome recorded
Phase 1/24 trials
Phase 1/2	NCT05123040	Jun 2023 → Feb 2026	acute graft versus host disease	Masonic Cancer Center, University of Minnesota	Terminated	No outcome recorded
Phase 1/2	NCT02525029	Mar 2016 → May 2021	acute graft versus host disease	Masonic Cancer Center, University of Minnesota	Completed	No outcome recorded
Phase 1/2	NCT02427529	May 2011 → Dec 2012	—	Dr. Emma's Corporation	Completed	No outcome recorded
Phase 1/2	NCT00839319	Mar 2009 → Sep 2010	—	University of Washington	Completed	No outcome recorded
Phase 24 trials
Phase 2	NCT02544191	Dec 2015 → Dec 2017	azoospermia	Jinling Hospital, China	Unknown	No outcome recorded
Phase 2	NCT01239706	Nov 2010 → Jun 2012	traumatic brain injury	University of Calgary	Unknown	No outcome recorded
Phase 2	NCT00938314	Aug 2009 → Apr 2010	ischemic stroke	Stem Cell Therapeutics Corp.	Terminated	No outcome recorded
Phase 2	NCT00697255	May 2007 → Apr 2008	female infertility	Organon and Co	Terminated	No outcome recorded
Phase 38 trials
Phase 3	NCT07216742	Nov 2025 → Nov 2028 expected	infertility disorder	Granata Bio Corporation	Recruiting	No outcome recorded
Phase 3	NCT05586802	Mar 2023 → Apr 2027 expected	Klinefelter syndrome	Georgios Papadakis	Recruiting	No outcome recorded
Phase 3	NCT02798653	Nov 2015 → Nov 2019	infertility disorder	Royan Institute	Unknown	No outcome recorded
Phase 3	NCT02825108	Jan 2015 → Dec 2018	infertility disorder	Royan Institute	Completed	No outcome recorded
Phase 3	NCT02355925	Oct 2014 → Dec 2018	infertility disorder	Royan Institute	Completed	No outcome recorded
Phase 3	NCT02310919	Sep 2014 → Jun 2018	infertility disorder	University of California, San Francisco	Completed	No outcome recorded
Phase 3	NCT01507376	Oct 2010 → Sep 2012	—	Royan Institute	Completed	No outcome recorded
Phase 3	NCT01081756	Dec 2003 → Sep 2004	female infertility	Merck KGaA, Darmstadt, Germany	Completed	No outcome recorded
Phase 422 trials
Phase 4	NCT05340010	Jan 2020 → Jun 2022	—	Alexandria University	Completed	No outcome recorded
Phase 4	NCT03846544	Oct 2019 → Sep 2021	infertility disorder	CRG UZ Brussel	Completed	No outcome recorded
Phase 4	NCT05638529	May 2019 → Dec 2023	female infertility, ovarian hyperstimulation syndrome	Mount Sinai Hospital, Canada	Unknown	No outcome recorded
Phase 4	NCT03687606	Oct 2018 → Oct 2024	Kallmann syndrome, infertility disorder	Tongji Hospital	Unknown	No outcome recorded
Phase 4	NCT03209687	Jul 2017 → Jul 2024	infertility disorder	Cairo University	Completed	No outcome recorded
Phase 4	NCT03115320	Jan 2017 → Nov 2019	infertility disorder	Tampere University Hospital	Terminated	No outcome recorded
Phase 4	NCT02880280	Aug 2016 → Aug 2017	Kallmann syndrome	Beijing Children's Hospital	Unknown	No outcome recorded
Phase 4	NCT02715336	Oct 2015 → Sep 2020	habitual spontaneous abortion, ovarian hyperstimulation syndrome, pregnancy disorder	Create Fertility Center	Unknown	No outcome recorded
Phase 4	NCT01980680	Dec 2014 → Sep 2019	infertility disorder	Peter Humaidan	Completed	No outcome recorded
Phase 4	NCT02329197	Oct 2014 → Oct 2015	infertility disorder	Mansoura University	Unknown	No outcome recorded
Phase 4	NCT01786252	Jan 2013 → Mar 2016	infertility disorder	Michigan State University	Completed	No outcome recorded
Phase 4	NCT01529177	Feb 2012 → Sep 2016	male infertility	The Egyptian IVF-ET Center	Unknown	No outcome recorded
Phase 4	NCT01768247	Jan 2012 → Dec 2013	—	University Hospital Brussels	Unknown	No outcome recorded
Phase 4	NCT01030393	Jan 2010 → Jan 2011	infertility disorder	The Egyptian IVF-ET Center	Completed	No outcome recorded
Phase 4	NCT00844311	Feb 2009 → Jun 2010	infertility disorder	Rigshospitalet, Denmark	Completed	No outcome recorded
Phase 4	NCT02638285	Jan → Aug 2009	pregnancy disorder	Shiraz University of Medical Sciences	Completed	No outcome recorded
Phase 4	NCT00976651	Jan → Nov 2009	infertility disorder	University Hospital Brussels	Completed	No outcome recorded
Phase 4	NCT00830492	Jan → Dec 2008	ovarian hyperstimulation syndrome	Yazd Research & Clinical Center for Infertility	Completed	No outcome recorded
Phase 4	NCT01601327	Jan 2008 → Mar 2012	hypogonadotropic hypogonadism	Gulhane School of Medicine	Completed	No outcome recorded
Phase 4	NCT00750100	Sep 2007 → Jan 2008	infertility disorder	University Hospital Brussels	Completed	No outcome recorded
Phase 4	NCT00415792	Nov 2003 → Jul 2005	infertility disorder	Eugonia	Unknown	No outcome recorded
Phase 4	NCT00286364	—	infertility disorder	Rigshospitalet, Denmark	Completed	No outcome recorded

Phase not applicable19 trials
—	NCT07633002	Jul 2026 → Dec 2027 expected	obesity disorder	The Second Hospital of Shandong University	Not yet recruiting	No outcome recorded
—	NCT07608133	Dec 2025 → Apr 2026	—	Pakistan Air Force (PAF) Hospital Islamabad	Completed	No outcome recorded
—	NCT06142708	Nov 2023 → Apr 2025	—	Embryolab Fertility Clinic	Unknown	No outcome recorded
—	NCT05103228	Dec 2021 → Jul 2023	infertility disorder, ovarian dysfunction	Peter Kovacs MD	Completed	No outcome recorded
—	NCT05569577	Jan 2021 → Dec 2025 overdue	rubeosis iridis	Fudan University	Recruiting	No outcome recorded
—	NCT04855383	Jul 2020 → Aug 2022	—	Royan Institute	Completed	No outcome recorded
—	NCT03682614	Dec 2018 → Aug 2019	infertility disorder	Reproductive & Genetic Hospital of CITIC-Xiangya	Completed	No outcome recorded
—	NCT03238807	Jul 2018 → Oct 2020	infertility disorder	Assiut University	Completed	No outcome recorded
—	NCT03445910	Feb → Jun 2018	infertility disorder	Ain Shams University	Completed	No outcome recorded
—	NCT03291821	Dec 2017 → Dec 2019	female infertility	IVI Madrid	Completed	No outcome recorded
—	NCT02870855	Jul 2017 → Jan 2018	infertility disorder	Reproductive & Genetic Hospital of CITIC-Xiangya	Withdrawn	No outcome recorded
—	NCT03825445	Apr 2016 → Jun 2017	female infertility	Hue University of Medicine and Pharmacy	Completed	No outcome recorded
—	NCT01986374	Jun 2013 → Dec 2015	infertility disorder	Servy Massey Fertility Insititute	Completed	No outcome recorded
—	NCT01931384	Jul 2012 → Dec 2015	infertility disorder	The University of Hong Kong	Completed	No outcome recorded
—	NCT02788136	Feb 2012 → Jul 2014	Klinefelter syndrome, steroid inherited metabolic disorder	Azienda USL Modena	Completed	No outcome recorded
—	NCT01780610	Jan 2012 → Jan 2015	infertility disorder	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Unknown	No outcome recorded
—	NCT01064219	Feb → Dec 2010	infertility disorder	The Egyptian IVF-ET Center	Completed	No outcome recorded
—	NCT00646568	Jun 2008 → Jan 2010	infertility disorder	Hadassah Medical Organization	Completed	No outcome recorded
—	NCT00223860	Jul 2001 → Dec 2007	hypogonadism, spinal cord injury	US Department of Veterans Affairs	Completed	No outcome recorded

Also used as a comparator or background therapy in 79 trials

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 01 trial
Phase 0	NCT02640976 Comparator	Jun 2013 → Jun 2015	female infertility	Cairo University	Completed	No outcome recorded
Phase 11 trial
Phase 1	NCT06367712 Comparator	Nov 2022 → Nov 2023	polycystic ovary syndrome	Egymedicalpedia	Completed	No outcome recorded
Phase 1/23 trials
Phase 1/2	NCT04071574 Comparator	Feb 2018 → Aug 2019	ectopic pregnancy, endometriosis, female infertility, hydrosalpinx +6	Lebanese University	Completed	No outcome recorded
Phase 1/2	NCT00947713 Comparator	Aug 2009 → Aug 2010	gonadal disorder	Royan Institute	Completed	No outcome recorded
Phase 1/2	NCT00823121 Comparator	Aug 2008 → Feb 2009	—	Yazd Research & Clinical Center for Infertility	Unknown	No outcome recorded
Phase 211 trials
Phase 2	NCT07481370 Comparator	Apr 2026 → Jun 2027 expected	azoospermia, oligospermia	University of Nebraska	Enrolling by invitation	No outcome recorded
Phase 2	NCT06904599 Comparator	Feb 2025 → Jan 2026 overdue	acute graft versus host disease	Hospital Universitario Dr. Jose E. Gonzalez	Recruiting	No outcome recorded
Phase 2	NCT07635082 Comparator	Feb 2024 → Jun 2025	polycystic ovary syndrome	Eman Basuni Ebrahim Mowad	Completed	No outcome recorded
Phase 2	NCT04189133 Comparator	Jan 2022 → Jan 2025	hypogonadotropic hypogonadism	University Hospital of Modena	Unknown	No outcome recorded
Phase 2	NCT04850261 Comparator	May 2021 → Mar 2024	infertility disorder	Insel Gruppe AG, University Hospital Bern	Withdrawn	No outcome recorded
Phase 2	NCT02551367 Background	Oct 2015 → May 2016	anovulation, polycystic ovary syndrome	mostafa gomaa hamid halawa	Unknown	No outcome recorded
Phase 2	NCT01204840 Comparator	Sep 2010 → May 2015	infertility disorder, ovarian dysfunction	Ottawa Fertility Centre	Completed	No outcome recorded
Phase 2	NCT01232075 Comparator	Sep 2008 → Nov 2010	infertility disorder	Cairo University	Completed	No outcome recorded
Phase 2	NCT00398229 Comparator	Nov 2006 → May 2008	female infertility	Hadassah Medical Organization	Completed	No outcome recorded
Phase 2	NCT00844350 Comparator	Oct 2006 → Sep 2007	ovarian disorder	Tabriz University	Completed	No outcome recorded
Phase 2	NCT00702806 Background	Jul 2001 → Oct 2002	infertility disorder	Organon and Co	Completed	No outcome recorded

Phase 2/31 trial
Phase 2/3	NCT04870502 Comparator	Apr 2019 → Jul 2020	polycystic ovary syndrome	Saudi German Hospital - Madinah	Completed	No outcome recorded
Phase 317 trials
Phase 3	NCT06725004 Comparator	Jan → Dec 2023	female infertility, polycystic ovary syndrome	Shakeela Ishrat	Completed	No outcome recorded
Phase 3	NCT04537078 Comparator	Sep 2020 → Mar 2021	female infertility	El Shatby University Hospital for Obstetrics and Gynecology	Completed	No outcome recorded
Phase 3	NCT06486870 Background	Jan 2020 → Jan 2024	polycystic ovary syndrome	Cairo University	Completed	No outcome recorded
Phase 3	NCT04224818 Background	Jul 2018 → Aug 2019	ovarian dysfunction	American University of Beirut Medical Center	Completed	No outcome recorded
Phase 3	NCT02862782 Background	Sep 2016 → Sep 2019	—	Tel-Aviv Sourasky Medical Center	Unknown	No outcome recorded
Phase 3	NCT02461173 Comparator	Jun 2015 → May 2017	infertility disorder	Cairo University	Unknown	No outcome recorded
Phase 3	NCT02469805 Comparator	Jun 2015 → Jun 2018	infertility disorder	Cairo University	Unknown	No outcome recorded
Phase 3	NCT02470169 Comparator	Jun 2015 → Jun 2017	infertility disorder	Cairo University	Unknown	No outcome recorded
Phase 3	NCT02264847 Comparator	Oct 2014 → Apr 2017	anovulation	Cairo University	Unknown	No outcome recorded
Phase 3	NCT02739516 Background	Jun 2014 → Aug 2015	infertility disorder	Benha University	Completed	No outcome recorded
Phase 3	NCT01599494 Background	Mar 2014 → May 2015	infertility disorder	Organon and Co	Withdrawn	No outcome recorded
Phase 3	NCT01709331 Background	Feb 2013 → Apr 2015	hypogonadotropic hypogonadism	Organon and Co	Completed	No outcome recorded
Phase 3	NCT01653743 Comparator	Sep 2012 → Nov 2014	anovulation, hypothalamic dysfunction, polycystic ovary syndrome	Merck KGaA, Darmstadt, Germany	Completed	No outcome recorded
Phase 3	NCT00948805 Background	Jan → Dec 2009	infertility disorder	University of Sao Paulo	Unknown	No outcome recorded
Phase 3	NCT00954265 Comparator	Aug 2005 → Dec 2007	Somatomedin, embryonic, perifoveal exudative vascular anomalous complex, pregnancy disorder	University Hospital Brussels	Unknown	No outcome recorded
Phase 3	NCT01084265 Background	Feb 2004 → Dec 2005	hypogonadism	Merck KGaA, Darmstadt, Germany	Completed	No outcome recorded
Phase 3	NCT00669786 Comparator	—	—	Instituto Valenciano de Infertilidad, IVI VALENCIA	Completed	No outcome recorded

Phase 428 trials
Phase 4	NCT06684951 Comparator	Oct 2022 → Jan 2024	female infertility	Omayma Ismail Khalaf	Completed	No outcome recorded
Phase 4	NCT04997525 Comparator	Apr 2021 → May 2024	infertility disorder	Copenhagen University Hospital at Herlev	Completed	No outcome recorded
Phase 4	NCT04724486 Background	Aug 2020 → Mar 2022	infertility disorder	Damascus University	Completed	No outcome recorded
Phase 4	NCT04727684 Background	Aug 2020 → Feb 2022	infertility disorder, polycystic ovary syndrome	Damascus University	Completed	No outcome recorded
Phase 4	NCT04727671 Background	Dec 2019 → Aug 2021	infertility disorder, polycystic ovary syndrome	Damascus University	Completed	No outcome recorded
Phase 4	NCT04724343 Background	Dec 2019 → Jan 2022	infertility disorder	Damascus University	Completed	No outcome recorded
Phase 4	NCT03784404 Comparator	Dec 2018 → Dec 2019	ovarian endometriosis	Cairo University	Unknown	No outcome recorded
Phase 4	NCT02896023 Comparator	Sep 2016 → Jan 2020	ovarian dysfunction	Cairo University	Unknown	No outcome recorded
Phase 4	NCT04008966 Comparator	Jul 2016 → Jun 2019	—	Cairo University	Completed	No outcome recorded
Phase 4	NCT02703584 Background	Mar 2016 → Sep 2018	infertility disorder	Mount Sinai Hospital, Canada	Completed	No outcome recorded
Phase 4	NCT02436226 Comparator	Mar 2016 → Jan 2023	female infertility, polycystic ovary syndrome	Mohamed Sayed Abdelhafez	Completed	No outcome recorded
Phase 4	NCT02458963 Comparator	Jan 2016 → Apr 2017	infertility disorder, polycystic ovary syndrome	Mohamed Sayed Abdelhafez	Withdrawn	No outcome recorded
Phase 4	NCT02397551 Comparator	Mar 2015 → Jan 2018	infertility disorder	Cairo University	Completed	No outcome recorded
Phase 4	NCT02288143 Background	Jan → Mar 2015	infertility disorder	University of Sao Paulo	Completed	No outcome recorded
Phase 4	NCT02048891 Comparator	Oct 2014 → Jan 2015	infertility disorder	Rambam Health Care Campus	Completed	No outcome recorded
Phase 4	NCT04605107 Comparator	Aug 2013 → Jan 2015	female infertility	Genuine Research Center, Egypt	Completed	No outcome recorded
Phase 4	NCT01815138 Comparator	Mar 2013 → Dec 2015	ovarian hyperstimulation syndrome	UConn Health	Completed	No outcome recorded
Phase 4	NCT01607203 Comparator	Nov 2011 → Dec 2013	infertility disorder	AZ Jan Palfijn Gent	Completed	No outcome recorded
Phase 4	NCT01225835 Background	Oct 2010 → Jan 2013	female infertility	Ferring Pharmaceuticals	Completed	No outcome recorded
Phase 4	NCT01888744 Comparator	Sep 2010 → Jun 2013	infertility disorder	University Hospital Brussels	Completed	No outcome recorded
Phase 4	NCT02310074 Comparator	Jan 2010 → Jun 2014	hypogonadotropic hypogonadism	Shanghai Jiao Tong University School of Medicine	Unknown	No outcome recorded
Phase 4	NCT01403532 Comparator	Sep 2009 → Dec 2012	Kallmann syndrome	Shanghai Jiao Tong University School of Medicine	Completed	No outcome recorded
Phase 4	NCT00627406 Comparator	Jan 2009 → Dec 2011	ovarian hyperstimulation syndrome	Regionshospitalet Viborg, Skive	Completed	No outcome recorded
Phase 4	NCT00870025 Comparator	Oct 2008 → Sep 2010	ovarian disorder	IVI Madrid	Completed	No outcome recorded
Phase 4	NCT01365936 Comparator	Jan → Jun 2008	polycystic ovary syndrome	Zekai Tahir Burak Women's Health Research and Education Hospital	Completed	No outcome recorded
Phase 4	NCT00439829 Background	Feb 2007 → May 2010	female infertility	University of Saskatchewan	Completed	No outcome recorded
Phase 4	NCT00953628 Comparator	Aug 2005 → Dec 2006	infertility disorder	University Hospital Brussels	Completed	No outcome recorded
Phase 4	NCT00298025 Background	Sep 2003 → May 2004	—	EMD Serono	Completed	No outcome recorded

Phase not applicable17 trials
—	NCT05828966 Comparator	Feb → May 2023	—	Shaheed Zulfiqar Ali Bhutto Medical University	Completed	No outcome recorded
—	NCT05874518 Comparator	Dec 2021 → Apr 2022	ovarian dysfunction	Liuzhou Maternity and Child Healthcare Hospital	Completed	No outcome recorded
—	NCT05112692 Comparator	Nov 2021 → Nov 2023	polycystic ovary syndrome	Mansoura University	Unknown	No outcome recorded
—	NCT03904355 Comparator	May 2019 → Apr 2022	female infertility	Cairo University	Unknown	No outcome recorded
—	NCT03904368 Comparator	Apr 2019 → Dec 2020	uterus interstitial leiomyoma	Cairo University	Unknown	No outcome recorded
—	NCT03402620 Comparator	Jan → Jun 2018	—	Cairo University	Completed	No outcome recorded
—	NCT03398993 Comparator	Jan → Dec 2018	infertility disorder	Cairo University	Unknown	No outcome recorded
—	NCT03307720 Comparator	Dec 2017 → Feb 2018	female infertility, ovarian disorder	Ginegorama S.L.	Unknown	No outcome recorded
—	NCT02940535 Background	Dec 2016 → Dec 2019	anovulation, female infertility	Navy General Hospital, Beijing	Unknown	No outcome recorded
—	NCT02827656 Comparator	Aug 2016 → Aug 2017	infertility disorder	Meir Medical Center	Unknown	No outcome recorded
—	NCT02775877 Comparator	May 2016 → Jun 2019	female infertility	Navy General Hospital, Beijing	Unknown	No outcome recorded
—	NCT02397642 Comparator	Mar 2015 → Jan 2018	infertility disorder	Cairo University	Completed	No outcome recorded
—	NCT03457233 Comparator	Jan 2015 → Mar 2018	—	Cairo University	Unknown	No outcome recorded
—	NCT02293668 Comparator	Nov 2014 → Aug 2015	infertility disorder	Istanbul University	Completed	No outcome recorded
—	NCT02158689 Comparator	Jun 2014 → Aug 2015	—	Ercan Bastu	Completed	No outcome recorded
—	NCT02148393 Comparator	May 2014 → Feb 2017	infertility disorder, ovarian hyperstimulation syndrome	University Hospital Brussels	Completed	No outcome recorded
—	NCT03484611 Comparator	Jan 2013 → Apr 2018	—	Cairo University	Unknown	No outcome recorded

Evidence & citations 33 cited values

Every value below carries the sentence it was read from. 155 sources stand behind the page.

Field	Value	Cited text
Known as	Human Chorionic Gonadotropin	“Although GnRHa triggering was shown to be as effective as human chorionic gonadotropin (hCG) at inducing oocyte maturation more than 20 years ago, its use to trigger ovulation...” NCT02715336 ↗ 88 “OBJECTIVE: To assess if triggering with 1,500 IU of human chorionic gonadotropin (hCG) with 450 IU of follicle-stimulating hormone (FSH) induces noninferior oocyte competence...” PMID 35705380 ↗ Jun 2022 “Human chorionic gonadotropin (hCG) administered by subcutaneous injection at a dose of 2,000 units three times weekly for 3 months as part of a randomized treatment arm...” NCT07481370 ↗ “When follicles achieve a diameter greater than 10 mm they start expressing luteinising hormone (LH) receptors. At this point, FSH might be replaced by low-dose human chorionic...” PMID 23543584 ↗ Mar 2013 “The purpose of this trial is to study whether addition of different doses of human chorionic gonadotropins during controlled ovarian stimulation for patients undergoing IVF...” NCT00844311 ↗ “Administration of 10000 IU of human chorionic gonadotropin (hCG; Choriomon®, IBSA) when at least 2 follicles measuring 18 mm are observed during vaginal ultrasound and is...” NCT02469805 ↗ “Administration of 10000 IU of human chorionic gonadotropin (hCG; Choriomon®, IBSA) when at least 2 follicles measuring 18 mm are observed during vaginal ultrasound and is...” NCT02470169 ↗ “When at least 3 follicles reached 18 mm, ovulation was triggered using Human Chorionic Gonadotropin 10000 IU (Epifasi 10000 IU; Eipico, Tenth of Ramadan, Egypt) IM and ovum...” NCT03784404 ↗ “In this clinical trial study, 52 patients with PCOS and 8 control cases were stimulated with human chorionic gonadotropin (HCG) on the 4(th) to 7(th) day of the patients'...” PMID 25780518 ↗ Feb 2015 “Luteal phase support (LPS) is one of the indispensable interventions in ART treatments for IHH patients, which includes progestin, estrogen, human chorionic gonadotropin (hCG),...” NCT05569577 ↗ “Human chorionic gonadotropin (HCG) hormone will replace the naturally surging luteinizing hormone at mid-cycle, subsequently, will lead to full maturation of oocytes resulting...” NCT06367712 ↗ “This randomized double blinded clinical trial is conducted to evaluate the effect of intrauterine injection of human chorionic gonadotropin (hCG) before frozen embryo transfer (ET).” NCT02825108 ↗ “OBJECTIVE: To characterize corpora lutea (CL) function after gonadotropin-releasing hormone agonist (GnRHa) trigger with the use of adjuvant human chorionic gonadotropin (hCG).” PMID 31227286 ↗ Jun 2019 “Then human menopausal gonadotropin (hMG) and human chorionic gonadotropin (hCG) were injected to stimulate them to ameliorate the ability of testicular spermatogenesis.” PMID 30243299 ↗ Sep 2018 “Luteal Phase Support With Human Chorionic Gonadotropin (hCG) Versus Gonadotropin Releasing Hormone (GnRh) Agonist in IVF Patients Who Are Risk for Developing OHSS” NCT02827656 ↗ “Routinely, human chorionic gonadotropin (hCG) is used for that purpose given its similarity to the natural hormone that does this job in a natural cycle” NCT02048891 ↗ “Human chorionic gonadotropin administration vs. luteinizing monitoring for intrauterine insemination timing, after administration of clomiphene citrate” PMID 17173907 ↗ Dec 2006 “When at least one dominant follicle reaches a mean diameter of 18-20 mm, human chorionic gonadotropin (hCG) will be administered to trigger ovulation.” NCT07635082 ↗ “intrauterine flushing with human chorionic gonadotropin was done to study the effect of this drug on ICSI outcome and ultrasound parameter.” NCT06684951 ↗ “Then ovulation triggering was done by an intramuscular single dose of human Chorionic Gonadotropin (Epifasi® 5000 IU vials, EIPICO, Egypt.)” NCT04870502 ↗ “including progesterone alone, human chorionic gonadotropin (hCG) alone, and the combination of progesterone with hCG, in these patients.” PMID 39827385 ↗ Jan 2025 “Human chorionic gonadotropin (hCG), is one of the initial embryonic signals and the major embryoendometrial relationship regulator.” NCT05340010 ↗ “patients will undergo a second triggering with human chorionic gonadotropin (hCG) 5000 IU and a second OR will be performed.” NCT03846544 ↗ “Human chorionic gonadotropin (Pregnyl; N.V. Organon, Oss, Holland) ( 10.000 IU/I.M ) is administered to trigger ovulation” NCT01232075 ↗ “evaluate the effect of intrauterine injection of human chorionic gonadotropin (hCG) before frozen embryo transfer (ET)” NCT02355925 ↗ “urinary human chorionic gonadotropin (u-hCG) 10,000 IU self-injected to complete final maturation of oocytes.” NCT01204840 ↗ “Human chorionic gonadotropin (hCG) is an early pre-implantation signal molecule secreted by the embryo” NCT03682614 ↗ “Exogenous human chorionic gonadotropin (hCG) acts on the final phase of the follicle maturation.” PMID 35137345 ↗ Feb 2022 “after the administration of human Chorionic Gonadotropin (hCG) on the first day of menses” NCT00948805 ↗ “Injection of hCG - Human Chorionic Gonadotropin (Ovitrelle 250 mcg mcg - Merck Serono)” NCT02862782 ↗ “Intrauterine Injection of Human Chorionic Gonadotropin to Enhance Embryo Implantation” NCT01986374 ↗ “Human chorionic gonadotropin(HCG),2000U,im,2 times/week, one year and a half” NCT01403532 ↗ “Testim (testosterone gel), Human Chorionic Gonadotropin (hCG) and acyline.” NCT00839319 ↗ “human Chorionic Gonadotropin (hCG, Pharmaceutical Partners of Canada Inc.)” NCT00439829 ↗ “human Chorionic Gonadotropin (Choriomon 10,000 IU subcutaneous once)” NCT04224818 ↗ “Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO)” NCT01239706 ↗ “self-injection of human Chorionic Gonadotropin (hCG)” NCT04850261 ↗ “Human Chorionic Gonadotropin (HCG) administration” NCT02638285 ↗ “Human Chorionic Gonadotropin (uhCG/EGF)” NCT05123040 ↗ “human chorionic gonadotropin (hCG)” NCT01709331 ↗ “HCG (human chorionic gonadotropin)” NCT01768247 ↗ “human Chorionic Gonadotropin” NCT04224818 ↗ NCT00223860 ↗ NCT00750100 ↗ NCT02788136 ↗ NCT04727671 ↗ NCT05586802 ↗ NCT02397642 ↗ NCT02310074 ↗ NCT06904599 ↗ NCT01888744 ↗ NCT04855383 ↗ NCT04008966 ↗ NCT02397551 ↗ NCT03307720 ↗ NCT02940535 ↗ NCT02880280 ↗ NCT00823121 ↗ NCT03115320 ↗ NCT02436226 ↗ NCT03445910 ↗ NCT06725004 ↗ NCT03904368 ↗ NCT03398993 ↗ NCT03904355 ↗ NCT03457233 ↗ NCT00398229 ↗ NCT04189133 ↗ NCT05828966 ↗ NCT00938314 ↗ NCT00646568 ↗ NCT03484611 ↗ NCT06142708 ↗ NCT01786252 ↗ NCT04724343 ↗ NCT01084265 ↗ NCT04727684 ↗ NCT01601327 ↗ NCT06754332 ↗ NCT03418896 ↗ NCT05112692 ↗ NCT04724486 ↗ NCT02739516 ↗ NCT03238807 ↗ NCT07633002 ↗ NCT00947713 ↗ NCT00870025 ↗ NCT03687606 ↗ NCT02427529 ↗
Known as	Chorimon	“Human chorionic gonadotropin Chorimon” NCT03457233 ↗
Known as	Choriomon	“40 μL of tissue culture medium (G.2plus ref. 10132, Vitrolife) containing either 500 IU of hCG (Choriomon®, IBSA SA, Switzerland) is injected intrauterine, approximately 7...” NCT02825108 ↗ 11 “Oxytocin (OXYTIP; manufactured by IPDIC, Rasht, Iran), 5 IU and hCG (Choriomon; manufactured by IBSA Institute Biochimique SA, CH-6903 Lugano), 5000 IU were also administrated...” NCT00844350 ↗ “Choriomon®, a highly purified hCG formulation, is approved in many European and extra-European countries for the induction of ovulation after stimulation of follicular development.” PMID 35137345 ↗ Feb 2022 “Intramuscular injection of 1,500 IU of hCG (Choriomon®; IBSA) on the embryos transfer (ET) day, as well as 4 days after the embryos transfer for luteal support” NCT02798653 ↗ “When one follicle reached a size of \> =18 mm a single dose of 10,000 IU human chorionic gonadotrophin (hCG, Pregnyl, Epifasi, Choriomon) is given.” NCT06486870 ↗ “Clomid 50 mg per day will be administered orally and human chorionic gonadotrophin ( choriomon ) 5000 IU will be administered IM once per week.” NCT01529177 ↗ “containing either 500 IU of hCG (Choriomon®, IBSA SA, Switzerland) is injected intrauterine” NCT02355925 ↗ “HCG triggering (Choriomon, IBSA, Lugano, Switzerland) in a dose of 10,000 IU” NCT04537078 ↗ “human Chorionic Gonadotropin (Choriomon 10,000 IU subcutaneous once)” NCT04224818 ↗ NCT02470169 ↗ NCT02461173 ↗ NCT02469805 ↗
Known as	Choriongonadotropin	ClinicalTrials.gov intervention name — accepted as the source's own label NCT01225835 ↗
Known as	Chorionic gonadotrophin	“When the diameter of follicles reaches 18mm, Chorionic gonadotrophin is given at 5000u (Lizhu Group Lizhu Pharmaceutical Factory, Chinese medicine H44020668, 5000u per branch),...” NCT05874518 ↗
Known as	Chorionic Gonadotropin, Alpha	ClinicalTrials.gov intervention name — accepted as the source's own label NCT04997525 ↗
Known as	EPICO	“a total of 10,000 IU of hCG (Epifasi, EPICO) was administered to those in whom at least one ovarian follicle was ≥18 mm in size.” NCT02739516 ↗
Known as	Epifasi	“When at least 3 follicles reached 18 mm, ovulation was triggered using Human Chorionic Gonadotropin 10000 IU (Epifasi 10000 IU; Eipico, Tenth of Ramadan, Egypt) IM and ovum...” NCT03784404 ↗ 3 “When one follicle reached a size of \> =18 mm a single dose of 10,000 IU human chorionic gonadotrophin (hCG, Pregnyl, Epifasi, Choriomon) is given.” NCT06486870 ↗ “a total of 10,000 IU of hCG (Epifasi, EPICO) was administered to those in whom at least one ovarian follicle was ≥18 mm in size.” NCT02739516 ↗ “Epifasi: Human chorionic gonadotrophin” NCT04605107 ↗
Known as	Gonasi HP	“The comparator is Gonasi HP.” NCT04189133 ↗
Known as	hCG	“Human chorionic gonadotropin (hCG) administered by subcutaneous injection at a dose of 2,000 units three times weekly for 3 months as part of a randomized treatment arm...” NCT07481370 ↗ 67 “The present study tested whether short-term androgen priming by aromatase inhibitor and human chorionic gonadotrophin (hCG) before controlled ovarian stimulation (COS)...” PMID 18487212 ↗ May 2008 “Administration of 10000 IU of human chorionic gonadotropin (hCG; Choriomon®, IBSA) when at least 2 follicles measuring 18 mm are observed during vaginal ultrasound and is...” NCT02469805 ↗ “Administration of 10000 IU of human chorionic gonadotropin (hCG; Choriomon®, IBSA) when at least 2 follicles measuring 18 mm are observed during vaginal ultrasound and is...” NCT02470169 ↗ “This randomised controlled trial (RCT) further explored whether low-dose hCG can be used clinically to replace recombinant FSH (rFSH) during the late follicular phase in a...” PMID 19617207 ↗ Jul 2009 “This randomized double blinded clinical trial is conducted to evaluate the effect of intrauterine injection of human chorionic gonadotropin (hCG) before frozen embryo transfer (ET).” NCT02825108 ↗ “The study population in frozen embryo transfer cycles receive three doses of human chorionic gonadotropin (HCG) to recognize the effectiveness of HCG on pregnancy outcomes” NCT04855383 ↗ “Then human menopausal gonadotropin (hMG) and human chorionic gonadotropin (hCG) were injected to stimulate them to ameliorate the ability of testicular spermatogenesis.” PMID 30243299 ↗ Sep 2018 “Ovulation will be triggered by the administration of 10,000 IU of Human Chorionic Gonadotropin (hCG) when at least three follicles become more than 16-17 mm.” NCT04727671 ↗ “Routinely, human chorionic gonadotropin (hCG) is used for that purpose given its similarity to the natural hormone that does this job in a natural cycle” NCT02048891 ↗ “When at least one dominant follicle reaches a mean diameter of 18-20 mm, human chorionic gonadotropin (hCG) will be administered to trigger ovulation.” NCT07635082 ↗ “Human Chorionic Gonadotropin (hCG) Priming Prior to Controlled Ovarian Hyperstimulation (COH) in Poor Responder In Vitro Fertilization (IVF) Patients” NCT00870025 ↗ “When one follicle reached a size of \> =18 mm a single dose of 10,000 IU human chorionic gonadotrophin (hCG, Pregnyl, Epifasi, Choriomon) is given.” NCT06486870 ↗ “including progesterone alone, human chorionic gonadotropin (hCG) alone, and the combination of progesterone with hCG, in these patients.” PMID 39827385 ↗ Jan 2025 “Human chorionic gonadotropin (hCG), is one of the initial embryonic signals and the major embryoendometrial relationship regulator.” NCT05340010 ↗ “patients will undergo a second triggering with human chorionic gonadotropin (hCG) 5000 IU and a second OR will be performed.” NCT03846544 ↗ “Administration of Human chorionic gonadotropin (HCG) 250 IU subcutaneously , 36 hours before ovum pick-up in IVF treatments.” NCT03307720 ↗ “Does injection oxytocin have similar ovulation rate as injection human chorionic gonadotropin (hCG) when used as trigger?” NCT06725004 ↗ “Human chorionic gonadotropin ( hCG) 10000 IU was given intramuscular when the mean ovarian follicle diameter was ≥18 mm.” NCT02739516 ↗ “evaluate the effect of intrauterine injection of human chorionic gonadotropin (hCG) before frozen embryo transfer (ET)” NCT02355925 ↗ “Human Chorionic Gonadotropin (HCG) and Clomiphene Citrate (CC) Versus Continued CC during Ovulation Induction” PMID 39202581 ↗ Aug 2024 “Human chorionic gonadotrophin ( hCG) was found to secreted immediately after fertilization by the embryo.” NCT01030393 ↗ “patients will receive low dose human chorionic gonadotropin (HCG) in combination with clomiphen citrate” NCT00947713 ↗ “Human chorionic gonadotropin (hCG) is an early pre-implantation signal molecule secreted by the embryo” NCT03682614 ↗ “Muscle-Sparing Effect Of Human Chorionic Gonadotropin (hCG) During a Very Low Calorie Diet (VLCD)” NCT02427529 ↗ “Exogenous human chorionic gonadotropin (hCG) acts on the final phase of the follicle maturation.” PMID 35137345 ↗ Feb 2022 “One of the earliest proteins produced by the embryo is human chorionic gonadotropin (hCG).” NCT01786252 ↗ “Human chorionic gonadotropin(HCG),2000U,im,2 times/week, one year and a half” NCT01403532 ↗ “The triggering will be performed using urinary hCG (5,000 IU subcutaneous).” NCT02288143 ↗ “Human Chorionic Gonadotropin (H.C.G.) is a heterodimeric glycoprotein” NCT05828966 ↗ “Human menopausal gonadotropin/human chorionic gonadotropin (HMG/HCG)” NCT02940535 ↗ “250 mg of hCG will be administered on the first day of menses” NCT00948805 ↗ “human chorionic gonadotropin (hCG), then epoetin alfa (EPO)” NCT00938314 ↗ “Human chorionic gonadotropin (hCG) (Pregnyl 5000 IU)” NCT01601327 ↗ “human chorionic gonadotropin (hCG; Choriomon®, IBSA)” NCT02461173 ↗ “10,000IU of hCG, every other day for three doses” NCT01239706 ↗ “Human chorionic gonadotrophin (hCG)” NCT07608133 ↗ “Human chorionic gonadotropin (hCG)” NCT06904599 ↗ “Human chorionic gonadotropin (hCG)” NCT00223860 ↗ “Human Chorionic Gonadotropin (hCG)” NCT04724486 ↗ “Human Chorionic Gonadotropin (hCG)” NCT04727684 ↗ “Human chorionic gonadotropin (hCG)” NCT01084265 ↗ “Human Chorionic Gonadotropin (hCG)” NCT04724343 ↗ “Human chorionic gonadotropin (hCG)” NCT02310074 ↗ “Low Dose hCG (Pregnyl)” NCT00627406 ↗ “1000IU of hCG i.m” NCT05112692 ↗ “Drug: hCG” NCT06684951 ↗ NCT02870855 ↗ NCT01986374 ↗ NCT02827656 ↗ NCT00439829 ↗ NCT00839319 ↗ NCT01815138 ↗ NCT05569577 ↗ NCT02265861 ↗ NCT02310919 ↗ NCT01980680 ↗ NCT05123040 ↗ NCT00844350 ↗ NCT01768247 ↗ NCT04850261 ↗ NCT02862782 ↗ NCT02715336 ↗ NCT01709331 ↗ NCT01414673 ↗ NCT03825445 ↗ NCT03682614 ↗ NCT02638285 ↗
Known as	hcg hormone	ClinicalTrials.gov intervention name — accepted as the source's own label NCT02551367 ↗
Known as	hMG	“ovarian stimulation will commence with recombinant Follicle-Stimulating Hormone (r-FSH) or r-FSH + human Menopausal Gonadotropin (hMG) and the dose will be adjusted according...” NCT04727684 ↗ 14 “Then human menopausal gonadotropin (hMG) and human chorionic gonadotropin (hCG) were injected to stimulate them to ameliorate the ability of testicular spermatogenesis.” PMID 30243299 ↗ Sep 2018 “Human Menopausal Gonadotrophin (HMG) 150-225 international unit/day (IU/d) via intramuscular injection” NCT05112692 ↗ “recombinant Follicle-Stimulating Hormone (r-FSH) or r-FSH + human Menopausal Gonadotropin (hMG)” NCT04724486 ↗ “recombinant Follicle-Stimulating Hormone (r-FSH) or r-FSH + human Menopausal Gonadotropin (hMG)” NCT04727671 ↗ “recombinant Follicle-Stimulating Hormone (r-FSH) or r-FSH + human Menopausal Gonadotropin (hMG)” NCT04724343 ↗ “Human Menopausal Gonadotropin (HMG) & - Recombinant Follicle Stimulating Hormone (r-FSH)” NCT00669786 ↗ “Human menopausal gonadotropin/human chorionic gonadotropin (HMG/HCG)” NCT02940535 ↗ “human menopausal gonadotropin (hMG)” NCT02158689 ↗ “Human Menopausal Gonadotropin (HMG)” NCT02458963 ↗ NCT01365936 ↗ NCT02293668 ↗ NCT02775877 ↗ NCT07216742 ↗ NCT00947713 ↗
Known as	hpHMG	“Highly purified hMG (hp-hMG) has recently shown better cycle outcome than the recombinant FSH (rFSH)” PMID 18583332 ↗ Jun 2008 1 “150 IU follitropin alpha + 75 IU highly purified human menopausal gonadotropin (hpHMG)” NCT05103228 ↗
Known as	human Chorion Gonadotropin (hCG)	ClinicalTrials.gov intervention name — accepted as the source's own label NCT00697255 ↗
Known as	human chorionic gonadotrophin	“The present study tested whether short-term androgen priming by aromatase inhibitor and human chorionic gonadotrophin (hCG) before controlled ovarian stimulation (COS)...” PMID 18487212 ↗ May 2008 11 “When one follicle reached a size of \> =18 mm a single dose of 10,000 IU human chorionic gonadotrophin (hCG, Pregnyl, Epifasi, Choriomon) is given.” NCT06486870 ↗ “Clomid 50 mg per day will be administered orally and human chorionic gonadotrophin ( choriomon ) 5000 IU will be administered IM once per week.” NCT01529177 ↗ “administration of human chorionic gonadotrophin (HCG) in patients undergoing intrauterine insemination (IUI) in natural cycles” PMID 22796236 ↗ May 2012 NCT04605107 ↗ NCT01931384 ↗ NCT05340010 ↗ NCT07608133 ↗ NCT01064219 ↗ NCT02264847 ↗ NCT01780610 ↗ NCT01030393 ↗
Known as	Human chorionic gonadotrophin (hCG)	ClinicalTrials.gov intervention name — accepted as the source's own label NCT07481370 ↗ 1 NCT02640976 ↗
Known as	Human Chorionic Gonadotropin(hCG)	“Human Chorionic Gonadotropin(hCG)” NCT02880280 ↗ 3 NCT04071574 ↗ NCT02329197 ↗ NCT01599494 ↗
Known as	Human hCG	“Human hCG 10'000 IU” NCT03735030 ↗
Known as	Human Menopausal Gonadotropin	“Then human menopausal gonadotropin (hMG) and human chorionic gonadotropin (hCG) were injected to stimulate them to ameliorate the ability of testicular spermatogenesis.” PMID 30243299 ↗ Sep 2018 25 “Control group (CC/hMG) will receive the 100 mg CC on days 3 to 7 of that cycle but will receive 150 mg human menopausal gonadotropin (HMG) during days of 7, 8, and 9.” NCT00947713 ↗ “human menopausal gonadotropin (hMG) 225IU/day will be initiated on the second or third day of spontaneous menstruation” NCT02293668 ↗ “Controlled ovarian stimulation was then started on day 3 using Human Menopausal Gonadotropin (Menogon; Ferring).” NCT03784404 ↗ “75 IU human menopausal gonadotropin (Menogon, ferring, pharmacenticals , Germany)” NCT00830492 ↗ “BACKGROUND: We aimed to compare human menopausal gonadotropin (hMG) and” PMID 24520446 ↗ Mar 2013 “Human menopausal gonadotropin 75 IU ampoules start at cycle day 2” NCT03402620 ↗ “Human Menopausal Gonadotropin, daily subcutaneous injection” NCT07216742 ↗ “Letrozole and human menopausal gonadotropin (HMG)” NCT02775877 ↗ “Human Menopausal Gonadotropin (HMG)” NCT02458963 ↗ “Human menopausal gonadotropin” NCT03484611 ↗ NCT04727671 ↗ NCT02880280 ↗ NCT02896023 ↗ NCT04727684 ↗ NCT03209687 ↗ NCT02940535 ↗ NCT03687606 ↗ NCT04724343 ↗ NCT02158689 ↗ NCT05112692 ↗ NCT00669786 ↗ NCT05103228 ↗ NCT03291821 ↗ NCT00976651 ↗ NCT04724486 ↗
Known as	Human Menopausal Gonadotropin(hMG)	“Human Menopausal Gonadotropin (HMG)” NCT02458963 ↗ 2 “Human Menopausal Gonadotropin(hMG)” NCT02880280 ↗ NCT00298025 ↗
Known as	Menogon	“Controlled ovarian stimulation was then started on day 3 using Human Menopausal Gonadotropin (Menogon; Ferring).” NCT03784404 ↗ 2 “stimulation with hMG (Menogon; Ferring Pharmaceuticals. Istanbul) or rFSH (Gonal-F; Serono Istanbul).” NCT01365936 ↗ “75 IU human menopausal gonadotropin (Menogon, ferring, pharmacenticals , Germany)” NCT00830492 ↗
Known as	merional	“HMG(merional, IBSA)” NCT03484611 ↗
Known as	Ovitrelle	“Injection of hCG - Human Chorionic Gonadotropin (Ovitrelle 250 mcg mcg - Merck Serono)” NCT02862782 ↗ 1 “s.c. human chorionic gonadotropin (Ovitrelle)” NCT00398229 ↗
Known as	Pregnyl	“After 2 months from the first Goserelin injection, all subjects were treated with hCG (Pregnyl, N.V. Organon Oss,Holland ) at a dose of 2000 IU once a week for 3 months.” NCT02544191 ↗ 17 “When one follicle reached a size of \> =18 mm a single dose of 10,000 IU human chorionic gonadotrophin (hCG, Pregnyl, Epifasi, Choriomon) is given.” NCT06486870 ↗ “Human chorionic gonadotropin (Pregnyl; N.V. Organon, Oss, Holland) ( 10.000 IU/I.M ) is administered to trigger ovulation” NCT01232075 ↗ “Human chorionic gonadotropin (Pregnyl, 5000IU) is used in the medication group to confirme the ovulation.” NCT03115320 ↗ “hCG (Pregnyl 5000IU) for ovulation trigger after ovarian stimulation for IUI.” NCT03825445 ↗ “Human chorionic gonadotropin (hCG) (Pregnyl 5000 IU)” NCT01601327 ↗ “Agonist trigger Buserelin 0,5 mg and Pregnyl (hCG)” NCT01980680 ↗ “s.c. human chorionic gonadotropin (Pregnyl)” NCT00646568 ↗ “Pregnyl: Human chorionic gonadotrophin” NCT04605107 ↗ “Pregnyl, hCG, 5000 IU times one im.” NCT03418896 ↗ NCT00627406 ↗ NCT01607203 ↗ NCT00702806 ↗ NCT05638529 ↗ NCT02525029 ↗ NCT02703584 ↗ NCT02148393 ↗ NCT00415792 ↗
Known as	rhCG	“When the follicle reached ≥18mm and estradiol reached ≥150pg/ml, recombinant human chorionic gonadotropin (rhCG) 250ug and triptorelin 0.1mg were co-administered to trigger ovulation.” NCT06754332 ↗
Known as	u-hCG	“urinary human chorionic gonadotropin (u-hCG) 10,000 IU self-injected to complete final maturation of oocytes.” NCT01204840 ↗ 1 “single dose of 5,000 IU u-hCG intramuscularly” NCT01653743 ↗
Known as	uhCG/EGF	“Human Chorionic Gonadotropin (uhCG/EGF)” NCT05123040 ↗
Known as	urinary HCG	“Urinary hCG (10,000 IU) injection s.c. or i.m.” NCT01081756 ↗ 4 NCT00953628 ↗ NCT01653743 ↗ NCT00954265 ↗ NCT01507376 ↗
Known as	Urofollitropin for Injection	“After 3 months from the first Goserelin injection, all subjects were treated with hMG (Urofollitropin for Injection, Livzon Pharm Group Inc., China) at a dose of 150 IU every 3...” NCT02544191 ↗
Action	Activate	“hCG was shown to up-regulate gene expression during the differentiation of human endometrial stromal cells into decidua.” NCT00398229 ↗
Modality	Protein / enzyme biologic	“Human menopausal gonadotropin (hMG)” NCT00298025 ↗
Route	Subcutaneous	“Human menopausal gonadotropin (hMG) will be administered subcutaneously” NCT00298025 ↗
Target	LHCGR	“Luteinizing hormone (LH) and human chorionic gonadotropin (hCG) are agonists for the luteinizing hormone receptor (LHCGR) which regulates male reproductive function.” PMID 33809538 ↗ Mar 2021